JP2020519654A5 - - Google Patents

Download PDF

Info

Publication number
JP2020519654A5
JP2020519654A5 JP2019562655A JP2019562655A JP2020519654A5 JP 2020519654 A5 JP2020519654 A5 JP 2020519654A5 JP 2019562655 A JP2019562655 A JP 2019562655A JP 2019562655 A JP2019562655 A JP 2019562655A JP 2020519654 A5 JP2020519654 A5 JP 2020519654A5
Authority
JP
Japan
Prior art keywords
solid form
disease
berberine
liver
ursodeoxycholic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019562655A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020519654A (ja
JP7685314B2 (ja
Filing date
Publication date
Priority claimed from CN201710335467.5A external-priority patent/CN108864077B/zh
Application filed filed Critical
Publication of JP2020519654A publication Critical patent/JP2020519654A/ja
Publication of JP2020519654A5 publication Critical patent/JP2020519654A5/ja
Priority to JP2023020228A priority Critical patent/JP7728295B2/ja
Application granted granted Critical
Publication of JP7685314B2 publication Critical patent/JP7685314B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019562655A 2017-05-12 2018-05-11 ベルベリンウルソデオキシコール酸の固体形態ならびにその組成物および方法 Active JP7685314B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023020228A JP7728295B2 (ja) 2017-05-12 2023-02-13 ベルベリンウルソデオキシコール酸の固体形態ならびにその組成物および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201710335467.5A CN108864077B (zh) 2017-05-12 2017-05-12 小檗碱有机酸盐的固体形式及其制备方法
CN201710335467.5 2017-05-12
PCT/CN2018/086461 WO2018205987A1 (en) 2017-05-12 2018-05-11 Solid forms of berberine ursodeoxycholate and compositions and methods thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023020228A Division JP7728295B2 (ja) 2017-05-12 2023-02-13 ベルベリンウルソデオキシコール酸の固体形態ならびにその組成物および方法

Publications (3)

Publication Number Publication Date
JP2020519654A JP2020519654A (ja) 2020-07-02
JP2020519654A5 true JP2020519654A5 (enExample) 2021-07-26
JP7685314B2 JP7685314B2 (ja) 2025-05-29

Family

ID=64105207

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019562655A Active JP7685314B2 (ja) 2017-05-12 2018-05-11 ベルベリンウルソデオキシコール酸の固体形態ならびにその組成物および方法
JP2023020228A Active JP7728295B2 (ja) 2017-05-12 2023-02-13 ベルベリンウルソデオキシコール酸の固体形態ならびにその組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023020228A Active JP7728295B2 (ja) 2017-05-12 2023-02-13 ベルベリンウルソデオキシコール酸の固体形態ならびにその組成物および方法

Country Status (10)

Country Link
US (3) US10959999B2 (enExample)
EP (2) EP3625229B9 (enExample)
JP (2) JP7685314B2 (enExample)
KR (2) KR20250017765A (enExample)
CN (1) CN108864077B (enExample)
AU (2) AU2018264384B2 (enExample)
CA (1) CA3062833A1 (enExample)
EA (1) EA201992607A1 (enExample)
ES (1) ES2988672T3 (enExample)
WO (1) WO2018205987A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108864077B (zh) * 2017-05-12 2020-05-22 深圳君圣泰生物技术有限公司 小檗碱有机酸盐的固体形式及其制备方法
CN110954645B (zh) * 2019-09-09 2020-09-29 山东琪康生物技术有限公司 一种高质量四黄止痢颗粒的检测方法
CN112851660B (zh) * 2019-11-12 2022-03-18 广东药科大学 含有小檗碱的酸-碱加成盐、其制备方法及其作为药物的用途
KR102636847B1 (ko) * 2020-09-18 2024-02-19 경북대학교 산학협력단 티아민 유도체를 포함하는 이식편대숙주질환 예방 또는 치료용 약학적 조성물
CN111920777A (zh) * 2020-09-18 2020-11-13 四川迪菲特药业有限公司 一种盐酸小檗碱片及其制备方法
EP4232045A4 (en) * 2020-10-23 2024-09-04 Shenzhen Hightide Biopharmaceutical Ltd. BERBERINE URSODEOXYCHOLATE COMPOSITIONS AND RELATED METHODS FOR THE TREATMENT OF FATTY LIVER, DIABETES AND HYPERLIPIDEMIA
US20230112845A1 (en) * 2020-10-23 2023-04-13 Shenzhen Hightide Biopharmaceutical Ltd. Compositions of berberine ursodeoxycholate and methods thereof for treating fatty liver disease, diabetes and hyperlipidemia
US20230346803A1 (en) * 2021-01-28 2023-11-02 Shenzhen Hightide Biopharmaceutical Ltd. Compositions of berberine ursodeoxycholate and methods thereof for treating primary sclerosing cholangitis
WO2022161468A1 (en) * 2021-01-28 2022-08-04 Shenzhen Hightide Biopharmaceutical Ltd. Compositions of berberine ursodeoxycholate and methods thereof for treating primary sclerosing cholangitis
WO2023088463A1 (en) * 2021-11-22 2023-05-25 Shenzhen Hightide Biopharmaceutical Ltd. Compositions and methods of berberine ursodeoxycholate for modulating gut microbiome compositions
CN114716498B (zh) * 2022-01-20 2024-01-23 成都贝诺科成生物科技有限公司 一种高稳定性的失碳熊去氧胆酸小檗碱盐晶型及其制备方法
CN115477647A (zh) * 2022-10-26 2022-12-16 山西医科大学 小檗碱富马酸盐晶型及其制备方法和其组合物与应用
WO2024120452A1 (en) * 2022-12-07 2024-06-13 Shenzhen Hightide Biopharmaceutical Ltd. Compositions and methods for prophylaxis and treatment of covid-19
EP4642454A1 (en) * 2022-12-30 2025-11-05 Shenzhen Hightide Biopharmaceutical Ltd. Pharmaceutical combinations and compositions, and methods of use thereof
CN120659782A (zh) * 2023-02-15 2025-09-16 深圳君圣泰生物技术有限公司 小檗碱牛磺熊去氧胆酸盐组合物及其方法
WO2024179570A1 (en) * 2023-03-01 2024-09-06 Shenzhen Hightide Biopharmaceutical Ltd. Compositions and methods for treating severe hypertriglyceridemia

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007005644A2 (en) 2005-07-01 2007-01-11 Concert Pharmaceuticals Inc. Novel aryloxypropanamines
US20070032555A1 (en) 2005-07-01 2007-02-08 Concert Pharmaceuticals Inc. Novel aryloxyphenyl-propanamines
KR20080047375A (ko) 2005-07-29 2008-05-28 콘서트 파마슈티컬즈, 인크. 약제 화합물
AU2006275595B2 (en) 2005-07-29 2012-08-16 Concert Pharmaceuticals Inc. Novel benzo [d] [1,3]-dioxol derivatives
CN102229636A (zh) * 2011-04-21 2011-11-02 东北林业大学 小檗碱9位酯键偶合胆酸的新衍生物及其制备方法
US9597337B2 (en) * 2014-04-04 2017-03-21 North American Biomedical Research Center Usa, Inc. Berberine-ursodeoxycholic acid conjugate for treating the liver
CN110179792A (zh) 2014-07-29 2019-08-30 深圳君圣泰生物技术有限公司 小檗碱盐、熊去氧胆酸盐、相关复方及其制备方法和应用
CN105693805A (zh) * 2016-03-15 2016-06-22 合肥华方医药科技有限公司 一种胆酸类小檗碱偶合物的制备及医药用途
CN108864077B (zh) * 2017-05-12 2020-05-22 深圳君圣泰生物技术有限公司 小檗碱有机酸盐的固体形式及其制备方法

Similar Documents

Publication Publication Date Title
JP2020519654A5 (enExample)
JP5129143B2 (ja) Mekインヒビターおよびその使用方法
JP2015514061A5 (enExample)
JP2011500621A5 (enExample)
EA201790124A1 (ru) Соли берберина, соли урсодезоксихолевой кислоты и их комбинации, способы получения и применения
CN115429784A (zh) 制备贝派地酸及其组合物的方法
JP2019519598A5 (enExample)
JP2018507914A5 (enExample)
JP2012532112A5 (enExample)
JP2017531688A5 (enExample)
UA121309C2 (uk) Дигідропіролопіридинові інгібітори ror-гамма
JP2014524442A5 (enExample)
JP2015510892A5 (enExample)
JP2013525444A5 (enExample)
JP2013536825A5 (enExample)
JP7159440B2 (ja) ジカチオン化合物及びその製造方法と使用
JP2008518904A5 (enExample)
JP2012523395A5 (enExample)
WO2014059232A3 (en) Substituted spiropiperidinyl compounds useful as gpr120 agonists
JP2007522142A5 (enExample)
CN111655678A (zh) 细胞凋亡信号调节激酶-1抑制剂及其应用
JP2015514781A5 (enExample)
JP2013523623A5 (enExample)
JP2014530818A5 (enExample)
JP2019533642A5 (enExample)